 | Up a level |
Spahn, M; Haeni, K (2012). [Approach to prostate cancer in men older than 75 years: active or passive?]. Urologe, 51(10), pp. 1368-74. Berlin: Springer-Verlag 10.1007/s00120-012-3011-6
Kälble, T; Hofmann, I; Thüroff, J W; Stein, R; Hautmann, R; Riedmiller, H; Vergho, D; Hertle, L; Wülfing, C; Truß, M; Roth, S; von Rundstedt, F C; Albers, P; Gschwend, J; Herkommer, K; Humke, U; Spahn, M; Bader, P; Steffens, J; Harzmann, R; ... (2012). [Secondary malignancies in urinary diversions]. Urologe, 51(4), 500, 502-6. Berlin: Springer 10.1007/s00120-012-2815-8
Spahn, M; Krebs, M (2012). [How should hormone therapy for castration-resistant prostate cancer be continued?]. Urologe, 51(1), pp. 15-19. Berlin: Springer 10.1007/s00120-011-2738-9
Spahn, M; Weiss, C; Bader, P; Frohneberg, D; Studer, U E; Burkhard, F C (2010). The role of exenterative surgery and urinary diversion in persistent or locally recurrent gynecological malignancy: complications and survival. Urologia internationalis, 85(1), pp. 16-22. Basel: Karger 10.1159/000296300
